Immediate Impact
1 from Science/Nature 8 standout
Citing Papers
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
2022 Standout
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
2021 Standout
Works of G. Marcacci being referenced
RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma
2011
Rituximab plus gemcitabine, ifosfamide, oxaliplatin (R-GIFOX) as salvage therapy for recurrent Hodgkin lymphoma
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. Marcacci | 36 | 55 | 9 | 39 | 10 | 88 | |
| Illja J. Diets | 35 | 44 | 14 | 26 | 8 | 105 | |
| Laure Deville | 38 | 54 | 33 | 36 | 13 | 195 | |
| Paraskevi Roussou | 41 | 61 | 21 | 19 | 9 | 173 | |
| Sébastien Orazio | 10 | 36 | 28 | 30 | 14 | 103 | |
| Namrata Shah | 13 | 66 | 3 | 49 | 11 | 95 | |
| Yun Jee Kang | 23 | 23 | 12 | 19 | 9 | 88 | |
| Carlo Sagramoso | 14 | 54 | 8 | 35 | 11 | 82 | |
| Christina Howlett | 43 | 140 | 9 | 93 | 11 | 166 | |
| Amaury Leruste | 16 | 28 | 11 | 34 | 12 | 79 | |
| Melissa Ortega | 24 | 54 | 3 | 13 | 10 | 77 |
All Works
Loading papers...